| Table 2: | |
|
Relevant
Vasoactive Mediators Released by Mast Cells and Basophils in Anaphylaxis
|
|
|
Mediator
|
Action
|
| Histamine | Vasodilation, bronchial and gastrointestinal smooth muscle contraction, mucus hypersecretion |
| Arachidonic
acid metabolites, including: Cysteinyl leukotrienes Prostaglandins Platelet-activating factor |
Bronchoconstriction, coronary vasoconstriction, increased vascular permeability, mucus hypersecretion, platelet adherence and aggregation, eosinophil activation and recruitment |
| Proteases,
including: Tryptase Chymase |
Cleavage of complement proteins and neuropeptides, inflammatory-cell chemoattractant, conversion of angiotensin I to angiotensin II, activation of protease-activated receptor-2 |
| Proteoglycans,
including: Heparin Chondroitin sulfate |
Anticoagulation, complement inhibition, eosinophil chemoattractant, kinin activation |
| Cytokines,
including: IL-3, -4, -5, -6, -10, and -13; granulocyte-macrophage colony-stimulating factor; tumor necrosis factor-α |
Eosinophil chemotaxis and activation; inflammatory cell activation and recruitment, induction of IgE-receptor expression, induction of apoptosis |
| Chemokines,
including: IL-8, MIP-1α |
Neutrophil chemotaxis, inflammatory cell recruitment, activation of NADPH oxidase |
| Nitric oxide | Vasodilation, increased vascular permeability |
|
Copyright
2004 The Cleveland Clinic Foundation
|